Predictors of Pegylated Interferone Treatment Response In HBeAg Negative Chronic Hepatitis B

被引：0
|
作者：
Guclu, Ertugrul [1 ]
Tuna, Nazan [1 ]
Karabay, Oguz [1 ]
机构：
[1] Sakarya Univ, Dept Infect Dis & Clin Microbiol, Minist Hlth, Training & Res Hosp, Sakarya, Turkey
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
452
引用
收藏
页码：414A / 415A
页数：2
相关论文
共 50 条
  • [21] Comparative efficacy of pegylated interferons α-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection
    Karabay, Oguz
    Tuna, Nazan
    Esen, Saban
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (11) : 1296 - 1301
  • [22] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [23] Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?
    Lampertico, Pietro
    Vigano, Mauro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2013, 33 : 157 - 163
  • [24] PEGYLATED INTERFERON ALFA-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B IN TAIWAN
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2010, 52 (04) : 549A - 549A
  • [25] Addition of (pegylated) interferon to entecavir increases response in treatment naive HBeAg-positive patients with chronic hepatitis B
    Liem, S.
    van Campenhout, M. J.
    Chi, H.
    Brouwer, W. P.
    Xie, Q.
    Qi, X.
    Liang, C.
    Tabak, F.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S692 - S692
  • [26] Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases?
    Nguyen, Mindie H.
    Keeffe, Emmet B.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (10) : 1312 - 1314
  • [27] Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan
    Lai, H. C.
    Peng, C. Y.
    Su, W. P.
    Chuang, P. H.
    Kao, J. T.
    Chou, J. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A175 - A175
  • [28] Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
    Rizzetto, M
    Tassopoulos, NC
    Goldin, RD
    Esteban, R
    Santantonio, T
    Heathcote, EJ
    Lagget, M
    Taak, NK
    Woessner, MA
    Gardner, SD
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 173 - 179
  • [29] Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others)
    Hadziyannis, SJ
    Papatheodoridis, GV
    JOURNAL OF HEPATOLOGY, 2003, 39 : S172 - S176
  • [30] Efficacy and safety of treatment interruption in patients with HBeAg negative chronic hepatitis B
    Broquetas, Teresa
    Mico, Miquel
    Garcia-Retortillo, Montserrat
    Canete Hidalgo, Nuria
    Puigvehi, Marc
    Coll, Susanna
    Batlle, Marc
    Viu, Ana
    Garrido, Esther
    Romero, Judit
    Jose Hernandez, Juan
    Bessa, Xavier
    Carrion, Jose A.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S860 - S860
12345